Ganaxolone

This classification denotes an antidepressant agent with the molecular formula C22H36O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98WI44OHIQ, chemically known as pregnan-20-one, 3-hydroxy-3-methyl-, (3alpha,5alpha)- but generally known as ganaxolone, which bears US NIH Compound Identifier 38022. European Medicines Agency schedules Ganaxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07880MIG. The term GANAXOLONE is an International Non-Proprietary Name. GANAXOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ganaxolone under HS 29144090 and SITC 51629. As of Q4 2014, GANAXOLONE remains the US FDA Preferred Term for this commodity. Ganaxolone bears US NLM identifiers UMLS ID C0537150 and NCI Concept Code C72793. SMILES: OC1(CC2C(C3C(C4C(CC3)(C(CC4)C(=O)C)C)CC2)(CC1)C)C.